Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods

K Loens1, H Goossens, M Ieven

  • 1Department of Microbiology, Vaccine and Infectious Disease Institute (VIDI), University of Antwerp, Antwerp, Belgium. Katherine.loens@ua.ac.be

Insights

Diagnosing respiratory infections caused by Mycoplasma pneumoniae is challenging due to a lack of standardized tests and quality assessments. This review examines diagnostic strategies and their impact on understanding M. pneumoniae

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Diagnostic Science

Background:

  • Mycoplasma pneumoniae is a significant cause of respiratory tract infections (RTIs).
  • Reliable diagnosis is hindered by the absence of standardized in-house and FDA-approved commercial diagnostic tests.
  • No formal external quality assessment schemes exist for M. pneumoniae diagnostic tests.

Purpose of the Study:

  • To review the current knowledge on M. pneumoniae-associated respiratory infections.
  • To emphasize diagnostic strategies and their impact on study results.
  • To discuss epidemiological studies from the past five years.

Main Methods:

  • Literature review of epidemiological studies published in the last 5 years.
  • Analysis of diagnostic strategies employed in these studies.
  • Evaluation of the impact of diagnostic methods on reported M. pneumoniae prevalence.

Main Results:

  • The role of M. pneumoniae in RTIs varies across studies due to geographical and epidemiological factors.
  • Inconsistent diagnostic techniques and criteria contribute to differing results.
  • Lack of standardized testing impacts the comparability of M. pneumoniae prevalence data.

Conclusions:

  • The diagnosis of Mycoplasma pneumoniae respiratory infections remains challenging.
  • Variability in diagnostic approaches affects the understanding of M. pneumoniae's epidemiological role.
  • Standardization of diagnostic tests and implementation of quality assessments are crucial.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...